Orlando Giuseppe, Manzia Tommaso Maria, Sorge Roberto, Iaria Giuseppe, Angelico Roberta, Sforza Daniele, Toti Luca, Peloso Andrea, Patel Timil, Katari Ravi, Zambon Joao Paulo, Maida Andrea, Salerno Maria Paola, Clemente Katia, Di Cocco Pierpaolo, De Luca Linda, Tariciotti Laura, Famulari Antonio, Citterio Franco, Tisone Giuseppe, Pisani Francesco, Romagnoli Jacopo
Wake Forest School of Medicine, Winston Salem, NC.
Department of Surgery, Section of Transplantation, Tor Vergata University of Rome, Rome, Italy.
Surgery. 2015 Jan;157(1):104-10. doi: 10.1016/j.surg.2014.06.007. Epub 2014 Oct 8.
There is no consensus on the optimal perioperative antibiotic prophylaxis regimen for renal transplant recipients. Some studies have reported that irrigation of the wound at the time of closure without systemic antibiotics may suffice to minimize the risk for surgical site infection (SSI), but many centers still use long-term, multidose regimens in which antibiotics are administered until removal of foreign bodies occur, such as the urethral catheter, drain and central line.
We designed a prospective, randomized, multicenter, controlled trial to compare a single dose versus a multidose regimen of systemic antibiotic prophylaxis in adult, nondiabetic, non-morbidly obese patients undergoing renal transplantation. The primary endpoint was the incidence of SSI; the assessment of other infection in the first postoperative month was the secondary endpoint.
Two hundred five patients were enrolled and randomized to receive either a single (n = 103) or multidose antibiotic regimen (n = 102) for prophylaxis. The incidences of SSI and urinary tract infection were similar in both groups.
As the dramatic increase in antibiotic resistance has mandated the implementation of global programs to optimize the use of antibiotic agents in humans, we believe that the single dose regimen is preferred, at least in nondiabetic, non-morbidly obese, adult renal transplant recipients.
对于肾移植受者围手术期最佳抗生素预防方案尚无共识。一些研究报告称,在伤口缝合时进行伤口冲洗而不使用全身性抗生素可能足以将手术部位感染(SSI)风险降至最低,但许多中心仍使用长期、多剂量方案,即一直使用抗生素直至异物(如尿道导管、引流管和中心静脉导管)拔除。
我们设计了一项前瞻性、随机、多中心对照试验,以比较接受肾移植的成年、非糖尿病、非病态肥胖患者使用单剂量与多剂量全身性抗生素预防方案的效果。主要终点是SSI的发生率;术后第一个月其他感染的评估为次要终点。
205例患者入组并随机接受单剂量(n = 103)或多剂量抗生素方案(n = 102)预防。两组的SSI和尿路感染发生率相似。
由于抗生素耐药性的急剧增加促使全球实施优化人类抗生素使用的计划,我们认为单剂量方案更可取,至少在非糖尿病、非病态肥胖的成年肾移植受者中如此。